Ozurdex

Allergan plc

Revision date : 2018-09-29

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 4
Safety risk rating 1
Environmental risk rating 1

General Information

Revision date

2018-09-29

Product name

Ozurdex

Product Synonyms

Dexamethasone Intravitreal Implant

1.2.1 Relevant identified uses

Indicated for the treatment of macular edema following branch retinal vein occlusion

Manufacturer Name

Allergan plc

Emergency telephone

1-800-424-9300, +1-703-741-5970

Icons in SDS

GHS08 M004 M009 M011 M059

Company Information

company name

Allergan plc

e-mail address of the competent person responsible for the Safety Data Sheet

SDS@Allergan.com

GHS Information

Signal word

Warning

Hazard Codes

Hazard statements (CLP)

H361, H362

Hazard statements

Code

Statements

H361

Suspected of damaging fertility or the unborn child

Section 2

SECTION 2: Hazards identification

OSHA Hazards Classification

2.2 Label elements

Emergency Overview Warning

Hazard statements

H361 - Suspected of damaging fertility or the unborn child H362 - May cause harm to breast-fed children Appearance Intravitreal Implant Physical state Solid Odor No information available Chemical Name Symptoms Dexamethasone Adverse effects include muscle wasting, muscle pain or weakness, delayed wound healing, and atrophy of the protein matrix of the bone resulting in osteoporosis, vertebral compression fractures, aseptic necrosis of femoral or humeral heads, or pathologic fractures of long bones are manifestations of protein catabolism which may occur during prolonged therapy with glucocorticoids. Chemical Name

Medical Conditions Generally Aggravated by Exposure

Dexamethasone Oral inhalation therapy should not be used in patients with untreated systemic fungal, bacterial, viral, or parasitic infections.

Precautionary statements

P202 - Do not handle until all safety precautions have been read and understood P281 - Use personal protective equipment as required P405 - Store locked up P501 - Dispose of contents/ container to an approved waste disposal plant P280 - Wear protective gloves/protective clothing/eye protection/face protection P201 - Obtain special instructions before use P260 - Do not breathe dust/fume/gas/mist/vapors/spray P263 - Avoid contact during pregnancy/while nursing P264 - Wash face, hands and any exposed skin thoroughly after handling P270 - Do not eat, drink or smoke when using this product P308 + P313 - IF exposed or concerned: Get medical advice/attention

Further information

Unknown Acute Toxicity 56% of the mixture consists of ingredient(s) of unknown toxicity

2.1 Classification of the substance or mixture

OSHA Regulatory Status This chemical is considered hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200) Reproductive toxicity Category 2 Effects on or via lactation Yes

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.